entertainment -WSS

entertainment

author：fashion 2025-09-29 01:45:27 - browse：8963

gantenerumab Alzheimer's disease Roche — Sebastien Bozon/AFP via Getty Images

LONDON — The booming obesity market is attracting another player, as pharma giant Roche said Monday it was acquiring Carmot Therapeutics and the company’s line of weight loss drug candidates for $2.7 billion upfront.

The deal for Carmot, which is based in Berkeley, Calif., includes additional milestone payments of up to $400 million. Carmot is privately held, though it had filed paperwork last month for an initial public offering.

As part of the deal, Roche is gaining three experimental obesity medicines from Carmot, which are in Phase 1 or Phase 2 testing, as well as preclinical programs. While two are injectable treatments, one is being developed as an oral drug. They all target GLP-1 hormone receptors, while two are also designed to work via receptors for another hormone called GIP.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Wegovy improves function in certain heart failure patients

WSS

Kim Kardashian sparks debate on benefits of full

The history of OxyContin, told through Purdue Pharma documents

How the first Native Hawaiian psychiatrist helped diversify medicine

TB outbreak tied to bone grafts underscores testing shortcomings

DeSantis wants to import drugs. Biden’s FDA blasted his plan

After John Oliver segment, STAT readers share their opioid

focus

entertainment

hotspot

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

The perfect storm of weather conditions that led to the devastating wildfires in Maui

Affirmative action in medical school literally saved lives

Maui funeral service workers on devastation of fires: 'I'm in shock'

Continuity nursing helped my family in our darkest PICU moments

DeSantis wants to import drugs. Biden’s FDA blasted his plan

Cancer drug shortages should be causing more outrage

Roche's accidental data boosts hopes for anti

Peter Hotez and the public health issue of online harassment

Novo acquires Inversago for up to $1 billion

entertainment

Kellogg’s is going to war over Mexico’s nutrition label rules

Who are the detained American citizens released from prison in Iran?

House GOP releases memo on Hunter Biden foreign business dealings, reviving old claims

The perfect storm of weather conditions that led to the devastating wildfires in Maui

Republicans love RFK Jr. What's that tell us about health in 2024?

Pharma budget tightening trickles down to Doximity

explore

Wikipedia

knowledge

leisure time